Sculptor Capital LP Dexcom Inc Transaction History

Sculptor Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $1.45 Million - $1.79 Million	-19,000 Reduced 51.56%	17,848 $1.44 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $1.77 Million - $3.46 Million	26,036 Added 240.81%	36,848 $2.75 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $498,435 - $689,799	-5,298 Reduced 32.89%	10,812 $5.53 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $921,947 - $1.16 Million	7,099 Added 78.78%	16,110 $8.65 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $961,563 - $1.29 Million	9,011 New	9,011 $4.93 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.